Trial Condition(s):

Pulmonary hypertension, Pulmonary Stenosis

Adalat drops and Adalat retard 10 mg tablets in children with pulmonary hypertension and with peripheral pulmonary stenosis

Bayer Identifier:

Trial_1555

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below

Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
33
Trial Dates
black-arrow
Phase
4
Could I receive a placebo?
No
Products
Adalat Retard (Nifedipine, BAYA1040)
Accepts Healthy Volunteers
N/A

Where to Participate

Locations
Status
LocationsStatus

For details, please refer to trial results

Additional Information